We found that serum RBP4 levels were positively associated with NAFLD in all subjects [odds ratio (OR) for the highest quartile vs. lowest quartile, 3.481 (95% CI: 2.806–4.320, P < 0.001). Here, RBP4 is linked to metabolic dysfunction-associated steatotic liver disease.